ATE413890T1 - Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort - Google Patents

Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort

Info

Publication number
ATE413890T1
ATE413890T1 AT05791035T AT05791035T ATE413890T1 AT E413890 T1 ATE413890 T1 AT E413890T1 AT 05791035 T AT05791035 T AT 05791035T AT 05791035 T AT05791035 T AT 05791035T AT E413890 T1 ATE413890 T1 AT E413890T1
Authority
AT
Austria
Prior art keywords
subject
vaccine
hormone
immune response
enhances
Prior art date
Application number
AT05791035T
Other languages
English (en)
Inventor
Ruxandra Draghia-Akli
Patrica Brown
Amir Khan
William Davis
Original Assignee
Advisys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advisys Inc filed Critical Advisys Inc
Application granted granted Critical
Publication of ATE413890T1 publication Critical patent/ATE413890T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05791035T 2004-07-23 2005-07-21 Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort ATE413890T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59073904P 2004-07-23 2004-07-23

Publications (1)

Publication Number Publication Date
ATE413890T1 true ATE413890T1 (de) 2008-11-15

Family

ID=35717476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05791035T ATE413890T1 (de) 2004-07-23 2005-07-21 Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort

Country Status (10)

Country Link
US (1) US20060025368A1 (de)
EP (1) EP1809336B1 (de)
JP (1) JP2008507537A (de)
CN (1) CN101027081A (de)
AT (1) ATE413890T1 (de)
AU (1) AU2005269724B2 (de)
DE (1) DE602005011041D1 (de)
MX (1) MX2007000893A (de)
NZ (1) NZ553274A (de)
WO (1) WO2006014737A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846720B2 (en) * 2005-01-26 2010-12-07 Vgx Pharmaceuticals, Inc. Optimized high yield synthetic plasmids
US20110282265A1 (en) * 2007-05-21 2011-11-17 Walters Richard E Method and apparatus for the delivery of plynucleotide vaccines to mammalia skin
WO2010044919A2 (en) * 2008-05-28 2010-04-22 Vgx Pharmaceuticals, Inc. Smallpox dna vaccine and the antigens therein that elicit an immune response
CN108707589B (zh) * 2018-06-07 2021-11-26 西南民族大学 一种牛病毒性腹泻病毒SMU-Z6/1a/SC/2016分离株及其应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224316A (en) * 1979-03-30 1980-09-23 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228156A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223019A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4226857A (en) * 1979-03-30 1980-10-07 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228158A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223021A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223020A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4410512A (en) * 1981-12-28 1983-10-18 Beckman Instruments, Inc. Combinations having synergistic pituitary growth hormone releasing activity
US5134120A (en) * 1984-08-03 1992-07-28 Cornell Research Foundation, Inc. Use of growth hormone to enhance porcine weight gain
US5036045A (en) * 1985-09-12 1991-07-30 The University Of Virginia Alumni Patents Foundation Method for increasing growth hormone secretion
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
US4833166A (en) * 1987-05-01 1989-05-23 Grosvenor Clark E Growth hormone releasing hormone complementary peptides
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
USRE33699E (en) * 1987-07-09 1991-09-24 International Minerals & Chemical Corp. Growth hormone-releasing factor analogs
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
US5023322A (en) * 1988-08-31 1991-06-11 Mta Kutatas-Es Szervezetelemzo Intezete Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5134210A (en) * 1989-07-27 1992-07-28 Edwards Bill R Acrylic resin composition
US5137872A (en) * 1989-09-18 1992-08-11 Pitman-Moore, Inc. Growth hormone-releasing factor analogs
ZA914983B (en) * 1990-06-29 1992-03-25 Hoffmann La Roche His-grf-analogs
US5486505A (en) * 1990-07-24 1996-01-23 Polygen Holding Corporation Polypeptide compounds having growth hormone releasing activity
EP0542937A1 (de) * 1991-04-09 1993-05-26 F. Hoffmann-La Roche Ag Analoge von wachstumshormonfreisetzenden faktoren (grf)
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
US5298422A (en) * 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
US5439440A (en) * 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5702359A (en) * 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US5792747A (en) * 1995-01-24 1998-08-11 The Administrators Of The Tulane Educational Fund Highly potent agonists of growth hormone releasing hormone
EP0820296A4 (de) * 1995-04-14 1999-06-30 Univ Tulane Analoge von wachstumshormon-freisetzungsfaktor
ES2278411T3 (es) * 1997-05-01 2007-08-01 Protechtion Unlimited, Inc. Factor de crecimiento nervioso como adyuvante de vacuna.
BR0001606A (pt) * 1999-04-12 2001-04-24 Pfizer Prod Inc Composições de hormÈnio de crescimento e de hormÈnio de liberação de hormÈnio de crescimento
US20020058039A1 (en) * 2000-04-27 2002-05-16 Coyne Michael J. Method of measuring the duration of adequate immune memory in companion animals
JP2005519035A (ja) * 2001-12-07 2005-06-30 インターツェル・アクチェンゲゼルシャフト 免疫促進性オリゴデオキシヌクレオチド
CA2469310C (en) * 2001-12-11 2013-01-29 Advisys, Inc. Plasmid mediated supplementation for treating chronically ill subjects
MXPA04011766A (es) * 2002-05-28 2005-03-31 Advisys Inc SUMINISTRO AUMENTADO DE UNA CONSTRUCCION DE áCIDO NUCLEICO IN VIVO POR EL SISTEMA DE POLO-L-GLUTAMATO (PLG).

Also Published As

Publication number Publication date
EP1809336B1 (de) 2008-11-12
WO2006014737A3 (en) 2006-05-11
AU2005269724A1 (en) 2006-02-09
AU2005269724B2 (en) 2011-03-10
JP2008507537A (ja) 2008-03-13
WO2006014737A2 (en) 2006-02-09
MX2007000893A (es) 2007-04-18
DE602005011041D1 (de) 2008-12-24
US20060025368A1 (en) 2006-02-02
NZ553274A (en) 2010-02-26
EP1809336A2 (de) 2007-07-25
CN101027081A (zh) 2007-08-29

Similar Documents

Publication Publication Date Title
RU2010149495A (ru) Новые адъювантные композиции
MXPA03011815A (es) Vacuna de micoplasma bovis y metodos para reducir la neumonia en animales.
AR061930A1 (es) Mimeticuerpos de glp-1 humanos, composiciones, metodos y usos
RU2008105348A (ru) Вакцина на основе lawsonia и способы ее применения
RU2007129840A (ru) Средства доставки, биологически активные вещества и вирусные вакцины
UA110328C2 (en) Recombinant vaccine based on avian paramixoviruses and method for its preparation and administration
Babiuk et al. Nucleic acid vaccines: research tool or commercial reality
US20160120628A1 (en) Fluttering ear tag for bovine vaccination
ATE413890T1 (de) Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
Mansoor et al. Intranasal delivery of nanoparticles encapsulating BPI3V proteins induces an early humoral immune response in mice
WO2002081621A3 (fr) Vaccin contre le virus de la fievre du nil
RU2010143584A (ru) Вакцина для защиты от haemophilus parasuis серотипа 4 у поросят
JP2012533557A (ja) 舌上ワクチン及びアプリケーター
UA96923C2 (ru) Вакцина на основе lawsonia и способы ее применения
Vos et al. Maternal immunity against rabies in raccoon dogs
Ebrahimi DNA Vaccine and its Importance in Veterinary
DK1337553T3 (da) Nucleinsyrevaccine omfattende et fusionsprotein inklusiv en adjuvanssekvens fra et vegetabilsk viralt kappeprotein
FR2804026B1 (fr) Vaccination contre l'herpesvirose canine et vaccins
Schrupp et al. Effect of Vaccinating Pre-Weaned Dairy Calves on Cell Mediated Immune Function
Biuk-Rudan et al. Specific and non-specific protection of pigs exposed to contact infection with Aujeszky's disease virus (ADV)
Lin et al. Development of a Multivalent Bacterial Vaccine for Vibrio alginolyticus, V. parahaemolyticus and Photobacterium damselae Subspecies piscicida and Its Evaluation in Cobia(Rachycentron canadum)
KR20120082194A (ko) 동물을 위한 예방백신 접종장치
RU2002115519A (ru) Способ вакцинопрофилактики эпидемического паротита на крайнем севере
Lojkić et al. VACCINATION PROGRAMS AGAINST ECONOMICALLY SIGNIFICANT INFECTIOUSE SWINE DISEASES IN THE REPUBLIC OF CROATIA

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties